FDA Drug · D-0757-2026

SEMAGLUTIDE 20mg (5mg/mL), Glycine 20 mg (5mg/mL), 4 mL Sterile Multi-Dose Vial, Rx Only, For Subcutaneous Injection Only, APOLLO care, 3801 Mojave Ct, Ste 102, Columbia, MO 65202. NDC 71170-724-04.

Class II · Ongoing

Presence of Particulate Matter; identified as a nylon/polyamide and silk/proteinaceous-type material

Affected lots / codes — check yours against thisLot: AC-017275, Exp. 12/13/2026; AC-017282, AC-017285, Exp. 12/27/2026.

Recalling firm: Apollo Care, LLC, Columbia, MO
Classification: Class II (temporary or reversible harm possible)
Status: Ongoing
Quantity: 4,250 vials.
Distribution: Nationwide within the U.S
Recall initiated: July 29, 2026
Classified: August 7, 2026
Initiation: Voluntary: Firm initiated

Official source. This record is published by the U.S. FDA through the openFDA enforcement database. View the unmodified government record:
https://api.fda.gov/drug/enforcement.json?search=recall_number%3A%22D-0757-2026%22

Important. Recalls target specific lots and codes — compare the affected lots above against your own product. This page reproduces public FDA data for readability; EveryRecall is independent and not affiliated with the FDA.

Check this brand across all 8 databases →